Perennial Allergic Rhinitis Study In Pediatric Subjects

Completed · Phase 3

Conditions studied: Rhinitis, Allergic, Perennial

In brief

The purpose of this study is to determine if the investigational drug is effective and safe in children with perennial allergic rhinitis.

Key facts

Study ID

NCT00108914

Run by

GlaxoSmithKline

People needed

558

Starts

2005-02-01

Expected to finish

2005-11-01

Last updated by the study team

2017-01-19

Who can join

Age: 2 and older, up to 12. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of perennial allergic rhinitis.

You may not qualify if…

• Have significant concomitant medical conditions.
• Use of corticosteroids or other allergy medications during the study.
• Have abnormal ECG.
• Have laboratory abnormality.
• Have abnormal eye exam.

Where it is running

• GSK Investigational Site — Cudahy, California, United States
• GSK Investigational Site — Long Beach, California, United States
• GSK Investigational Site — Long Beach, California, United States
• GSK Investigational Site — Orange, California, United States
• GSK Investigational Site — Riverside, California, United States
• GSK Investigational Site — Sacramento, California, United States
• GSK Investigational Site — San Diego, California, United States
• GSK Investigational Site — San Diego, California, United States
• GSK Investigational Site — Walnut Creek, California, United States
• GSK Investigational Site — Denver, Colorado, United States
• GSK Investigational Site — Denver, Colorado, United States
• GSK Investigational Site — Englewood, Colorado, United States
• GSK Investigational Site — Coral Gables, Florida, United States
• GSK Investigational Site — Gainesville, Georgia, United States
• GSK Investigational Site — Lawrenceville, Georgia, United States
• GSK Investigational Site — Stockbridge, Georgia, United States
• GSK Investigational Site — Metairie, Louisiana, United States
• GSK Investigational Site — Shreveport, Louisiana, United States
• GSK Investigational Site — Baltimore, Maryland, United States
• GSK Investigational Site — Ypsilanti, Michigan, United States
• GSK Investigational Site — Jackson, Mississippi, United States
• GSK Investigational Site — Kansas City, Missouri, United States
• GSK Investigational Site — Omaha, Nebraska, United States
• GSK Investigational Site — Omaha, Nebraska, United States
• GSK Investigational Site — Costa Mesa, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.